Skip to content

Pharmacy

NCPA urges PBM reform in major media print ads

NCPA urges PBM reform in major media print ads

In print ads Tuesday in the Washington Post and the Wall Street Journal, the National Community Pharmacists Association is urging policymakers to rein in pharmacy benefit managers to help lower drug costs.

Upsher-Smith acquires two products from Dr. Reddy’s

Upsher-Smith acquires two products from Dr. Reddy’s

MAPLE GROVE, Minn. – Upsher-Smith recently announced that it has completed the acquisition of Tosymra (sumatriptan) Nasal Spray, 10 mg, and Zembrace SymTouch (sumatriptan) Injection 3 mg from Dr. Reddy’s Laboratories. The products were previously commercialized through Dr.

NACDS hotline rallies industry to urge DIR relief

NACDS hotline rallies industry to urge DIR relief

With the Senate Finance Committee expected to begin making decisions on spending bills as early as today, the National Association of Chain Drug Stores has launched a telephone hotline — (866) DIR-RE4M — that pharmacy advocates can use to urge the inclusion of DIR fee relief in drug-pricing legislat

Walmart and Sam’s Club offering talking Rx labels

Walmart and Sam’s Club offering talking Rx labels

Walmart and Sam’s Club are deeply committed to accessibility and medication safety for their blind, visually impaired and print-impaired pharmacy patients. To enhance their commitment, Walmart and Sam’s Club pharmacies provide En-Vision America’s ScripTalk audible (i.e.

Amneal among companies to launch generic version of Lyrica

Amneal among companies to launch generic version of Lyrica

The Food and Drug Administration has approved a number of applications for the generic version of Pfizer’s Lyrica (pregabalin). The  FDA gave the green light to the following companies: Amneal, Alembic, Alkem, Dr. Reddy’s, InvaGen, MSN Laboratories, Rising Pharmaceuticals, Sciegen, and Teva.

Walgreens expands Find Care platform

Walgreens expands Find Care platform

Walgreens announced Monday that it has expanded the Walgreens Find Care platform to now include chronic care management, featuring connected devices and digital therapeutic solutions for patients with diabetes, asthma and chronic obstructive pulmonary disease (COPD).

CVS Pharmacy names Murphy SVP, payer relations and managed care

CVS Pharmacy names Murphy SVP, payer relations and managed care

CVS Pharmacy has named Kevin Murphy, Jr., senior vice president, payer relations and managed care. In this role, Murphy will oversee negotiation for all retail reimbursement contracts with third-party payors and develop new methods of contracting with PBMs and Health Plans.

DIR fee relief urgency clear at NACDS board member D.C. fly-in

DIR fee relief urgency clear at NACDS board member D.C. fly-in

Ten NACDS board of directors members met with key members of Congress in Washington, D.C. this week. The meetings focused on conveying the urgent need for direct and indirect remuneration (DIR) fee relief. The timing was ideal, given that decisions are being made now about drug-pricing legislation.

CVS to start trial for home Hemodialysis device

CVS to start trial for home Hemodialysis device

CVS Health announced Wednesday the initiation of a clinical trial designed to evaluate the safety and efficacy of the HemoCare Hemodialysis System for administration of home hemodialysis. The innovative device includes safety features and is designed to make home hemodialysis simple for patients.

NCPA announces finalists for student awards

NCPA announces finalists for student awards

The National Community Pharmacists Association announced that three teams of pharmacy students have been named finalists in the 2019 Good Neighbor Pharmacy NCPA Pruitt-Schutte Student Business Plan Competition.